Urgent.News

What's breaking now, across thousands of outlets.

AI

Biocon Chair: AI in Clinical Trials Is the Holy Grail

Biocon Executive Chairperson Kiran Mazumdar-Shaw told Bloomberg's Francine Lacqua that a wave of expiring biologic patents provides a major runway to expand affordable cancer biosimilars and elevate the company above its current top-five global ranking. Speaking on the sidelines of the Bloomberg New Economy Forum in New Delhi, Mazumdar-Shaw added that while AI accelerates molecular discovery, the…

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in AI

Discovery Phase AI vs ChatGPT: an honest comparison

ChatGPT is a good tool for drafting parts of a discovery phase: a problem statement, a first list of requirements, a summary of a call.

  • ChatGPT excels in initial stages of discovery, drafting problem statements and requirements
  • Discovery Phase AI specializes in comprehensive discovery documents over multiple stages
  • Discovery Phase AI offers structured approach, consistency checks, and version history

More from Thursday 15 October →